Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep 8;8(4):659-71.
doi: 10.5114/aoms.2012.30290.

Gene polymorphisms of ABC transporters are associated with clinical outcomes in children with acute lymphoblastic leukemia

Xiaowen Zhai  1 , Hongsheng Wang, Xiaohua Zhu, Hui Miao, Xiaowen Qian, Jun Li, Yijin Gao, Fengjuan Lu, Yue Wu
Affiliations

Gene polymorphisms of ABC transporters are associated with clinical outcomes in children with acute lymphoblastic leukemia

Xiaowen Zhai et al. Arch Med Sci. .

Abstract

Introduction: Genetic variability affects clinical outcome in pediatric acute lymphocytic leukemia (ALL) patients. Evaluating gene polymorphisms in ABC transporters could help identify relapse risk and predict outcome.

Material and methods: The SNaPshot SNP technique was used to analyze single-nucleotide polymorphisms (SNPs) in the multidrug transporter 1 (MDR1), multidrug resistance associated proteins (MRP1, MRP2) and breast cancer resistance protein (BCRP) genes of 82 pediatric ALL patients. The association between the SNPs with risk of all events and death as well as with survival was evaluated by the univariate Cox proportional hazard model.

Results: The BCRP G34A SNP was the only SNP significantly associated with ALL. Risk factors included pre-treatment WBC counts and post-treatment peripheral and bone marrow leukemic cell counts. We found no association between MDR1 SNPs with these factors. The BCRP C421A C/A and C/C genotypes were significantly associated with low pre-treatment WBC counts while MRP2 G1249A G/G was significantly associated with low levels of post-treatment peripheral and bone marrow leukemic cells. A combination of C1236T, G1249A and/or G34A SNPs was significantly associated with lower EFS and OS.

Conclusions: Polymorphisms associated with risk of ALL and clinical outcome may be potential biomarkers to predict clinical outcome and improve prognosis in childhood ALL.

Keywords: acute lymphoblastic leukemia; outcome; single nucleotide polymorphism; survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Survival analysis for EFS (A ) and OS (B ) using the combinations of the C1236, G1249 and the G34A
See this image and copyright information in PMC

References

    1. Howlader N, Noone AM, Krapcho M. SEER Cancer Statistics Review, 1975-2008. National Cancer Institute. SEER Website. http://seer.cancer.gov/csr/1975_2008/. Accessed November 10, 2011.
    1. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med. 1998;339:605–15. - PubMed
    1. Apostolidou E, Swords R, Alvarado Y, Giles FJ. Treatment of acute lymphoblastic leukaemia: a new era. Drugs. 2007;67:2153–71. - PubMed
    1. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166–78. - PubMed
    1. Yang JJ, Cheng C, Yang W, et al. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA. 2009;301:393–403. - PMC - PubMed